Evidence mapping of clinical research on traditional Chinese medicine in treatment of renal anemia.
10.19540/j.cnki.cjcmm.20250226.502
- Author:
Ke-Xin ZHANG
1
;
Xin LI
2
;
Kai-Li CHEN
1
;
Peng-Tao DONG
1
;
Lu-Yao SHI
1
;
Lin-Qi ZHANG
1
Author Information
1. Department of Nephrology, First Affiliated Hospital of Henan University of Chinese Medicine Zhengzhou 450099, China.
2. the Fifth People's Hospital of Anyang Anyang 455000, China.
- Publication Type:English Abstract
- Keywords:
evidence mapping;
randomized controlled trial;
renal anemia;
systematic review;
traditional Chinese medicine
- MeSH:
Humans;
Anemia/drug therapy*;
Drugs, Chinese Herbal/therapeutic use*;
Medicine, Chinese Traditional;
Kidney Diseases/drug therapy*
- From:
China Journal of Chinese Materia Medica
2025;50(12):3413-3422
- CountryChina
- Language:Chinese
-
Abstract:
Through evidence mapping, this paper systematically summarized the research evidence on the use of traditional Chinese medicine(TCM) in treating renal anemia, displaying the distribution of evidence in this field. A systematic search was conducted across databases, including CNKI, Wanfang, VIP, SinoMed, Springner, PubMed, Engineering Village, and Web of Science, targeting studies published up to June 30, 2024. The research evidence was summarized and displayed through a combination of graphs, tables, and text. A total of 264 interventional studies, 37 observational studies, and 7 systematic reviews were included. The annual publication volumes related to TCM treatment in renal anemia showed an overall upward trend, with most studies involving sample sizes between 60 and 120 participants(224 articles, 74.42%). Intervention measures were categorized into 21 types, with oral TCM decoctions being the most common medicine(171 times, 56.81%). The use of self-made prescriptions was the most common TCM intervention method. The intervention duration was mainly between 8 weeks and 3 months(239 articles, 79.40%). The most frequently reported TCM syndrome was spleen and kidney Qi deficiency. The top 2 outcome indicators were the anemia indicators and renal injury/renal function markers. However, several issues were identified in these studies, such as insufficient attention to the sources, social/geographical information, and temporal continuity of research subjects in observational research. Randomized controlled trials mostly had a high risk of bias, mainly due to issues such as randomization bias, blinding bias, and failure to register research protocols. The methodology quality of systematic reviews was generally low, mainly due to inadequate inclusion of literature, failure to specify funding sources, and lack of pre-registrations. While the report quality of systematic review was acceptable, there were significant gaps in the reporting of protocols, registration, and funds. The results show that these issues affect the quality of research and the reliability of findings on TCM in treating renal anemia, underscoring the need to address them to conduct higher-quality research and provide more reliable medical evidence for TCM in treating renal anemia.
